This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Societe De Commercialisation Des Produits De La Recheche Appliquee-Socpra-Science Sante Et Humaines S.e.c., Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines S.e.c.. Active years: 2011-2022.
Company Filing History:
1 out of 1 
1 out of 10 Years Active: 2011-2022
Title: David Fortin: Innovator in Cancer Therapeutics
Introduction
David Fortin is a notable inventor based in Sherbrooke, Canada. He has made significant contributions to the field of cancer therapeutics, particularly through his innovative approaches to diagnosis and treatment. With a total of 2 patents, Fortin's work focuses on developing novel chemical entities that enhance the efficacy of cancer treatments.
Latest Patents
Fortin's latest patents include "Kinin-based theranostic probes for solid cancers and uses thereof." This invention introduces new chemical entities that allow for simultaneous diagnosis and treatment of cancers. Specifically, it provides a theranostic compound consisting of a stabilized peptide ligand for the kinin B1 receptors conjugated to specific radionuclides, such as copper, suitable for dual imaging and radiotherapy applications. Another significant invention involves novel kinin B1 receptors peptide agonists that exhibit excellent affinities and selectivity for the B receptor. These compounds demonstrate increased resistance to enzymatic degradation and superior pharmacokinetic properties compared to naturally occurring agents. They also enhance the delivery of chemotherapeutic substances across the blood-brain barrier and protect organ functions when used in combination with other therapies.
Career Highlights
Throughout his career, David Fortin has worked with various organizations, including the Société de Commercialisation des Produits de la Recherche Appliquée and Socpra Sciences Santé et Humaines. His innovative work has positioned him as a key figure in the development of advanced therapeutic solutions for cancer treatment.
Collaborations
Fortin has collaborated with notable professionals in his field, including Fernand Gobeil and Domenico Regoli. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
David Fortin's contributions to cancer therapeutics through his innovative patents highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the diagnosis and treatment of solid cancers.